AGLE - アエグリア・バイオセラピュ―ティクス (Aeglea BioTherapeutics Inc.)

AGLEのニュース

   Can We See Significant Institutional Ownership On The Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Share Register?  2019/07/17 19:47:06 Yahoo Finance
If you want to know who really controls Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), then you'll have to look at the…
   Aeglea BioTherapeutics misses by $0.04  2019/05/07 11:49:52 Seeking Alpha
   Aeglea BioTherapeutics (AGLE) Investor Presentation - Slideshow  2019/04/08 17:59:43 Seeking Alpha
   Aeglea (AGLE) Reports New Positive Data for Pegzilarginase  2019/04/08 09:30:00 Zacks Investment Research
Aeglea (AGLE) reports new positive data for pegzilarginase in patients with Arginase 1 Deficiency.
   Aeglea BioTherapeutics started at overweight with $14 stock price target at J.P. Morgan  2019/03/21 11:28:36 MarketWatch
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
   Can We See Significant Institutional Ownership On The Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Share Register?  2019/07/17 19:47:06 Yahoo Finance
If you want to know who really controls Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), then you'll have to look at the…
   Aeglea BioTherapeutics misses by $0.04  2019/05/07 11:49:52 Seeking Alpha
   Aeglea BioTherapeutics (AGLE) Investor Presentation - Slideshow  2019/04/08 17:59:43 Seeking Alpha
   Aeglea (AGLE) Reports New Positive Data for Pegzilarginase  2019/04/08 09:30:00 Zacks Investment Research
Aeglea (AGLE) reports new positive data for pegzilarginase in patients with Arginase 1 Deficiency.
   Aeglea BioTherapeutics started at overweight with $14 stock price target at J.P. Morgan  2019/03/21 11:28:36 MarketWatch
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
   Can We See Significant Institutional Ownership On The Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Share Register?  2019/07/17 19:47:06 Yahoo Finance
If you want to know who really controls Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), then you'll have to look at the…
   Aeglea BioTherapeutics misses by $0.04  2019/05/07 11:49:52 Seeking Alpha
   Aeglea BioTherapeutics (AGLE) Investor Presentation - Slideshow  2019/04/08 17:59:43 Seeking Alpha
   Aeglea (AGLE) Reports New Positive Data for Pegzilarginase  2019/04/08 09:30:00 Zacks Investment Research
Aeglea (AGLE) reports new positive data for pegzilarginase in patients with Arginase 1 Deficiency.
   Aeglea BioTherapeutics started at overweight with $14 stock price target at J.P. Morgan  2019/03/21 11:28:36 MarketWatch
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

calendar